- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 28
- Grants since 2016
- 3 213
Grants received
2020–2027 · research · R35
Towards targeting the lymphoma microenvironment
Hans-Guido Wendel · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Leveraging implementation science to accelerate adoption of shorter-course radiation for breast and prostate cancer
Erin Faye Gillespie · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers
Ricardo Otazo · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer
Michelle S Bradbury · Kettering University · funded by National Institutes of Health
2020–2021 · research · R01
Exploring the link between serine metabolism and epigenetic in lymphoma
Hans-Guido Wendel · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
David A Scheinberg · Kettering University · funded by National Institutes of Health
2020–2026 · research · R01
Cancer and Aging Reflections for Elders (CARE): A Geriatric-Specific Psychotherapy for Older Adults with Cancer
Christian J Nelson · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint
Craig B Thompson · Kettering University · funded by National Institutes of Health
2020–2026 · cooperative agreement · U01
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
Jada Gabrielle Hamilton · Kettering University · funded by National Institutes of Health
2020–2025 · research · R37
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient
Jesse Joshua Smith · Kettering University · funded by National Institutes of Health
2020–2025 · program · P50
MSK SPORE in Genomic Instability in Breast Cancer
Simon N. Powell · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE)
Jun J Mao · Kettering University · funded by National Institutes of Health
2020–2025 · program · P50
MSK SPORE in Genomic Instability in Breast Cancer
Simon N. Powell · Kettering University · funded by National Institutes of Health
2020–2025 · research · R37
Investigating HIF1-alpha Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid-Type Fibromatosis
Aimee Marie Crago · Kettering University · funded by National Institutes of Health
2020–2025 · research · R35
DNA Damage & DNA Replication: a Complex Relationship
John Hj Petrini · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
Danny Khalil · Kettering University · funded by National Institutes of Health
2020–2022 · career development · K99
Interrogating oncogene-dependency and mutation order in FLT3 mutant AML
Robert Lyle Bowman · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
Ming Li · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Investigating microRNA Function in Homeostasis, Regeneration and Cancer
Andrea Ventura · Kettering University · funded by National Institutes of Health
2020–2025 · research · R35
Investigating histone glycation as a new dynamic epigenetic mark
Yael E David-Shternberg · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2020–2022 · career development · K99
Interrogating oncogene-dependency and mutation order in FLT3 mutant AML
Robert Lyle Bowman · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint
Craig B Thompson · Kettering University · funded by National Institutes of Health
2020–2021 · cooperative agreement · UG3
Arylepoxamides: A new class of potent, safer analgesics
Ying-Xian Pan · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
Ming Li · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Toward development of senolytic CAR T cells
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2020–2023 · research · R33
Comprehensive breakpoint analyses for simultaneous quantification of all DNA double strand break repair pathways
Daniel Higginson · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
Benjamin Greenbaum · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
Ming Li · Kettering University · funded by National Institutes of Health
2020–2025 · research · R37
Investigating HIF1-alpha Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid-Type Fibromatosis
Aimee Marie Crago · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
Danny Khalil · Kettering University · funded by National Institutes of Health
2020–2026 · research · R01
Exercise as Interception Therapy in Primary High Risk Cancer
Luis A Diaz · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Discovery of diabetes-relevant ò cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens
Effie Apostolou · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
Jada Gabrielle Hamilton · Kettering University · funded by National Institutes of Health
2020–2023 · cooperative agreement · UE5
MSK Immuno-Oncology for the Translational Researcher Short Course
Ushma Neill · Kettering University · funded by National Institutes of Health
2020–2026 · program · P50
MSK SPORE in Genomic Instability in Breast Cancer
Simon N. Powell · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
David A Scheinberg · Kettering University · funded by National Institutes of Health
2020–2026 · research · R01
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
Michael J Morris · Kettering University · funded by National Institutes of Health
2020–2030 · research · R01
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
Nancy Y Lee · Kettering University · funded by National Institutes of Health
2020–2026 · research · R01
Improving radiolabeled imaging and targeting of HER2 positive EG cancers using lovastatin
Yelena Y Janjigian · Kettering University · funded by National Institutes of Health